Clinical significance of androgen secretion disorders in men with a malignancy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical significance of androgen secretion disorders in men with a malignancy
Authors
Keywords
Testosterone, Hypogonadism, Testicular cancer, Prostate cancer, Metastatic cancer
Journal
MEDICAL ONCOLOGY
Volume 34, Issue 7, Pages -
Publisher
Springer Nature
Online
2017-06-01
DOI
10.1007/s12032-017-0982-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics
- (2016) A. Lipton et al. EUROPEAN JOURNAL OF CANCER
- Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer
- (2016) Kathryn T. Dinh et al. JOURNAL OF CLINICAL ONCOLOGY
- Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison
- (2016) Ashley M. Nelson et al. SUPPORTIVE CARE IN CANCER
- Adipokines in Patients With Cancer Anorexia and Cachexia
- (2016) Joanna Smiechowska et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- A 24-Month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial
- (2015) Bente L. Langdahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison
- (2015) Brian D. Gonzalez et al. JOURNAL OF UROLOGY
- Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study
- (2015) Linda Sharp et al. PSYCHO-ONCOLOGY
- The Prevalence of Cardiac Risk Factors in Men with Localized Prostate Cancer Undergoing Androgen Deprivation Therapy in British Columbia, Canada
- (2015) Margot K. Davis et al. Journal of Oncology
- Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis
- (2015) Cecilia Bosco et al. PLoS One
- Association between hypogonadism, symptom burden, and survival in male patients with advanced cancer
- (2014) Rony Dev et al. CANCER
- Testosterone deficiency and quality of life in Australasian testicular cancer survivors: a prospective cohort study
- (2014) B. O'Carrigan et al. INTERNAL MEDICINE JOURNAL
- Intermittent androgen deprivation is a rational standard-of-care treatment for all stages of progressive prostate cancer: results from a systematic review and meta-analysis
- (2014) D Brungs et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2014) Heather L. McGinty et al. SUPPORTIVE CARE IN CANCER
- Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
- (2013) P M Willemse et al. BRITISH JOURNAL OF CANCER
- Cardiovascular Morbidity Associated with Gonadotropin Releasing Hormone Agonists and an Antagonist
- (2013) Peter C. Albertsen et al. EUROPEAN UROLOGY
- Intermittent versus Continuous Androgen Deprivation in Prostate Cancer
- (2013) Maha Hussain et al. NEW ENGLAND JOURNAL OF MEDICINE
- Testosterone replacement for fatigue in hypogonadal ambulatory males with advanced cancer: a preliminary double-blind placebo-controlled trial
- (2013) E. Del Fabbro et al. SUPPORTIVE CARE IN CANCER
- Early development of the metabolic syndrome after chemotherapy for testicular cancer
- (2012) E. C. de Haas et al. ANNALS OF ONCOLOGY
- Low Testosterone Levels and Increased Inflammatory Markers in Patients with Cancer and Relationship with Cachexia
- (2012) Basil O. Burney et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Performance of Total Testosterone Measurement to Predict Free Testosterone for the Biochemical Evaluation of Male Hypogonadism
- (2012) Bradley D. Anawalt et al. JOURNAL OF UROLOGY
- The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression
- (2012) Evan Ng et al. JOURNAL OF UROLOGY
- Androgen deprivation therapy through bilateral orchiectomy: increased metabolic risks
- (2011) Juan-Jie Bo et al. ASIAN JOURNAL OF ANDROLOGY
- A prospective, randomized pilot study evaluating the effects of metformin and lifestyle intervention on patients with prostate cancer receiving androgen deprivation therapy
- (2011) Jenny P. Nobes et al. BJU INTERNATIONAL
- The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancer
- (2011) Mikkel Bandak et al. EUROPEAN JOURNAL OF CANCER
- Onset of effects of testosterone treatment and time span until maximum effects are achieved
- (2011) Farid Saad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- 1095 PREVALENCE OF METABOLIC SYNDROME IN PROSTATE CANCER PATIENTS UNDER ANDROGEN DEPRIVATION THERAPY: INTERIM RESULTS OF A CASE-CONTROL STUDY
- (2011) J. Ropero Valverde et al. EUROPEAN UROLOGY SUPPLEMENTS
- Androgen Deprivation Therapy and Cardiovascular Risk
- (2011) Sanoj Punnen et al. JOURNAL OF CLINICAL ONCOLOGY
- Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis
- (2011) A Serpa Neto et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Clinical exercise interventions in prostate cancer patients—a systematic review of randomized controlled trials
- (2011) Freerk T. Baumann et al. SUPPORTIVE CARE IN CANCER
- Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study
- (2010) Svetlana Y. Kalinchenko et al. CLINICAL ENDOCRINOLOGY
- Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment
- (2010) G. Pühse et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Population-Based Study of Cardiovascular Mortality Among Patients With Prostate Cancer Treated With Radical External Beam Radiation Therapy With and Without Adjuvant Androgen Deprivation Therapy at the British Columbia Cancer Agency
- (2010) Julian Kim et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Impact of Androgen-Deprivation Therapy on Cognitive Function in Men With Nonmetastatic Prostate Cancer
- (2010) Shabbir M.H. Alibhai et al. JOURNAL OF CLINICAL ONCOLOGY
- The Efficacy and Safety of Testosterone Undecanoate (Nebido®) in Testosterone Deficiency Syndrome in Korean: A Multicenter Prospective Study
- (2010) Du Geon Moon et al. Journal of Sexual Medicine
- Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life
- (2010) Stacy Elliott et al. Journal of Sexual Medicine
- Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome
- (2010) Erik J. Giltay et al. Journal of Sexual Medicine
- Interaction of gonadal status with systemic inflammation and opioid use in determining nutritional status and prognosis in advanced pancreatic cancer
- (2010) Richard J. E. Skipworth et al. SUPPORTIVE CARE IN CANCER
- Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality
- (2009) Jakob Eberhard et al. JOURNAL OF AFFECTIVE DISORDERS
- Impact of Androgen Deprivation Therapy on Cardiovascular Disease and Diabetes
- (2009) Shabbir M.H. Alibhai et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Long-Acting Testosterone Treatment on Functional Exercise Capacity, Skeletal Muscle Performance, Insulin Resistance, and Baroreflex Sensitivity in Elderly Patients With Chronic Heart Failure
- (2009) Giuseppe Caminiti et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
- (2009) N. L. Keating et al. JNCI-Journal of the National Cancer Institute
- Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial
- (2009) Jacques Irani et al. LANCET ONCOLOGY
- Managing hot flushes in men after prostate cancer—A systematic review
- (2009) Jessica Frisk MATURITAS
- Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer
- (2009) M. ONDRUSOVA et al. NEOPLASMA
- Androgen Deficiency Symptoms in Testicular Cancer Survivors Are Associated With Sexual Problems but Not With Serum Testosterone or Therapy
- (2009) Jakob E. Lackner et al. UROLOGY
- Management of complications of androgen deprivation therapy in the older man
- (2008) Supriya G. Mohile et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Risk factors for post-treatment hypogonadism in testicular cancer patients.
- (2008) Jakob Eberhard et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02
- (2008) Jason A. Efstathiou et al. EUROPEAN UROLOGY
- Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
- (2008) Christina Wang et al. EUROPEAN UROLOGY
- Adipocytokines, Obesity, and Insulin Resistance During Combined Androgen Blockade for Prostate Cancer
- (2008) Matthew R. Smith et al. UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started